Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Brian Sauer

Concepts (391)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
42
2024
1003
6.740
 Why?
Antirheumatic Agents
24
2024
255
5.990
 Why?
Veterans
32
2023
1249
4.480
 Why?
Spondylitis, Ankylosing
5
2020
43
2.590
 Why?
Hyperkalemia
3
2023
26
2.450
 Why?
Veterans Health
8
2023
165
2.290
 Why?
United States Department of Veterans Affairs
12
2021
561
2.170
 Why?
Methotrexate
10
2021
226
1.970
 Why?
Medication Adherence
7
2019
536
1.500
 Why?
Spondylarthritis
3
2020
36
1.380
 Why?
Natural Language Processing
4
2023
72
1.380
 Why?
Registries
18
2024
1768
1.350
 Why?
Biological Products
6
2021
166
1.310
 Why?
Rheumatology
2
2020
88
1.300
 Why?
Drug-Related Side Effects and Adverse Reactions
5
2019
238
1.260
 Why?
Tumor Necrosis Factor-alpha
6
2024
1140
1.170
 Why?
Drug Substitution
3
2021
46
1.000
 Why?
Aged
46
2024
19074
1.000
 Why?
Psoriasis
2
2015
74
0.940
 Why?
Arthritis, Psoriatic
3
2019
16
0.880
 Why?
Lymphoma, Follicular
2
2021
35
0.880
 Why?
Middle Aged
47
2024
26738
0.870
 Why?
Sulfasalazine
3
2019
21
0.850
 Why?
Humans
96
2024
114699
0.840
 Why?
Lung Diseases, Interstitial
6
2024
508
0.840
 Why?
Hydroxychloroquine
3
2019
54
0.820
 Why?
United States
31
2023
12186
0.810
 Why?
Misoprostol
1
2022
18
0.800
 Why?
HLA-B27 Antigen
3
2019
11
0.800
 Why?
Electronic Health Records
6
2023
800
0.790
 Why?
Databases, Factual
7
2018
1125
0.790
 Why?
Cohort Studies
16
2024
4895
0.760
 Why?
Analgesics, Opioid
5
2020
771
0.730
 Why?
Severity of Illness Index
12
2023
2540
0.730
 Why?
Practice Patterns, Physicians'
5
2019
1177
0.720
 Why?
Rituximab
2
2021
150
0.710
 Why?
Infliximab
3
2016
94
0.700
 Why?
Male
54
2024
55606
0.690
 Why?
Treatment Outcome
19
2024
9088
0.680
 Why?
Buprenorphine
1
2023
134
0.680
 Why?
Insurance Claim Review
2
2017
67
0.680
 Why?
Algorithms
5
2020
1470
0.680
 Why?
Pharmaceutical Services
2
2019
77
0.660
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2022
299
0.660
 Why?
Prostatic Neoplasms, Castration-Resistant
1
2019
40
0.650
 Why?
Arthritis
2
2021
109
0.630
 Why?
Datasets as Topic
1
2019
100
0.620
 Why?
Iron
2
2021
233
0.620
 Why?
Anemia, Iron-Deficiency
1
2019
53
0.620
 Why?
Antineoplastic Agents, Immunological
1
2020
152
0.620
 Why?
Etanercept
2
2016
51
0.600
 Why?
Adalimumab
2
2016
44
0.600
 Why?
Female
49
2024
59520
0.580
 Why?
Renal Insufficiency, Chronic
2
2021
486
0.580
 Why?
Kidney Failure, Chronic
1
2022
489
0.570
 Why?
Chronic Pain
3
2022
210
0.570
 Why?
Risk Factors
24
2024
8632
0.540
 Why?
Computer Simulation
4
2020
873
0.530
 Why?
Opioid-Related Disorders
1
2023
413
0.520
 Why?
Terminology as Topic
1
2017
187
0.520
 Why?
Cross-Over Studies
1
2017
440
0.510
 Why?
Delivery of Health Care
2
2022
833
0.510
 Why?
Diabetes Mellitus
3
2024
900
0.510
 Why?
Research Design
3
2020
928
0.490
 Why?
Healthcare Common Procedure Coding System
1
2014
2
0.480
 Why?
Hospitalization
5
2021
1752
0.460
 Why?
Insurance, Pharmaceutical Services
2
2011
23
0.460
 Why?
Cytokines
5
2024
1841
0.460
 Why?
Adipokines
3
2022
42
0.460
 Why?
Ambulatory Care
2
2014
478
0.440
 Why?
Models, Statistical
2
2017
599
0.440
 Why?
Narcotics
1
2013
44
0.430
 Why?
Emergency Service, Hospital
3
2023
1820
0.420
 Why?
Time Factors
12
2023
6116
0.420
 Why?
Comparative Effectiveness Research
1
2013
130
0.410
 Why?
Health Services Accessibility
2
2019
763
0.410
 Why?
Utah
7
2013
59
0.410
 Why?
Potassium
2
2023
128
0.400
 Why?
Drug Prescriptions
2
2013
239
0.400
 Why?
Remission Induction
3
2022
233
0.400
 Why?
Decision Support Systems, Clinical
2
2012
176
0.390
 Why?
Medicine
1
2013
102
0.390
 Why?
Pharmaceutical Preparations
3
2022
165
0.390
 Why?
Proportional Hazards Models
8
2022
1075
0.380
 Why?
Drug Overdose
2
2012
292
0.380
 Why?
Retrospective Studies
18
2023
12555
0.370
 Why?
Disease Progression
2
2018
2380
0.370
 Why?
Carpal Bones
2
2021
14
0.370
 Why?
Inflammatory Bowel Diseases
1
2015
284
0.360
 Why?
Cardiovascular Diseases
7
2023
1727
0.350
 Why?
Practice Guidelines as Topic
2
2019
1395
0.350
 Why?
Adiponectin
4
2024
213
0.350
 Why?
Potentially Inappropriate Medication List
2
2020
14
0.340
 Why?
Aged, 80 and over
13
2021
6347
0.330
 Why?
Quality Indicators, Health Care
1
2012
287
0.330
 Why?
C-Reactive Protein
4
2021
362
0.330
 Why?
Body Mass Index
6
2018
1959
0.330
 Why?
Risk Assessment
10
2021
2968
0.320
 Why?
Prospective Studies
9
2024
6220
0.310
 Why?
Kaplan-Meier Estimate
3
2021
811
0.310
 Why?
Incidence
9
2024
2313
0.310
 Why?
Antibodies, Monoclonal
1
2014
1262
0.300
 Why?
Health Knowledge, Attitudes, Practice
2
2013
1183
0.300
 Why?
ROC Curve
3
2019
442
0.290
 Why?
Pneumonia, Bacterial
2
2020
106
0.290
 Why?
International Classification of Diseases
4
2023
116
0.280
 Why?
Multimorbidity
2
2023
33
0.270
 Why?
Predictive Value of Tests
4
2020
1796
0.270
 Why?
Adult
16
2022
30553
0.260
 Why?
Managed Care Programs
1
2007
133
0.260
 Why?
Propensity Score
3
2020
224
0.260
 Why?
Arthrodesis
3
2021
105
0.250
 Why?
Drug Therapy, Combination
2
2019
951
0.250
 Why?
Drug Utilization
2
2018
167
0.250
 Why?
Patient Admission
1
2007
176
0.240
 Why?
Embryo, Nonmammalian
2
2005
173
0.240
 Why?
Neoplasms
5
2023
2097
0.230
 Why?
Gene Targeting
1
2004
75
0.230
 Why?
Alarmins
1
2024
25
0.230
 Why?
Data Mining
3
2023
100
0.230
 Why?
Interleukin-33
1
2024
38
0.230
 Why?
Regression Analysis
3
2018
945
0.230
 Why?
Embryo, Mammalian
1
2004
213
0.220
 Why?
Wrist
2
2021
48
0.220
 Why?
Weight Loss
2
2018
642
0.220
 Why?
Follow-Up Studies
7
2021
4411
0.220
 Why?
Wrist Joint
2
2021
59
0.210
 Why?
Poisson Distribution
2
2017
71
0.210
 Why?
Stroke
2
2021
1022
0.210
 Why?
Comorbidity
4
2023
1448
0.200
 Why?
Rheumatic Diseases
1
2023
49
0.200
 Why?
Diclofenac
1
2022
14
0.200
 Why?
Blood Sedimentation
2
2019
32
0.200
 Why?
Chemokines
2
2021
216
0.200
 Why?
Research Report
1
2022
75
0.200
 Why?
Genetic Testing
1
2004
381
0.190
 Why?
Confidence Intervals
2
2016
305
0.190
 Why?
Polymerase Chain Reaction
1
2004
993
0.190
 Why?
Linear Models
3
2018
768
0.190
 Why?
Waldenstrom Macroglobulinemia
1
2021
11
0.180
 Why?
Multivariate Analysis
5
2018
1430
0.180
 Why?
Hospitals, Veterans
3
2018
244
0.180
 Why?
Maintenance Chemotherapy
1
2020
22
0.180
 Why?
Arthritis, Infectious
1
2021
49
0.180
 Why?
Cyclophosphamide
2
2021
217
0.170
 Why?
Prosthesis-Related Infections
1
2021
70
0.170
 Why?
Prescription Drugs
2
2012
116
0.170
 Why?
Stem Cells
1
2004
546
0.170
 Why?
Pneumonia, Staphylococcal
1
2020
13
0.170
 Why?
Neoplasm Grading
1
2020
242
0.170
 Why?
SEER Program
1
2020
196
0.170
 Why?
Bipolar Disorder
1
2021
205
0.170
 Why?
Transferrin
1
2019
39
0.160
 Why?
Arthroplasty, Replacement, Hip
1
2021
109
0.160
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2020
98
0.160
 Why?
Ferritins
1
2019
52
0.160
 Why?
Inappropriate Prescribing
1
2019
52
0.160
 Why?
Coronary Artery Disease
2
2022
607
0.160
 Why?
Geriatrics
1
2019
69
0.160
 Why?
Ranolazine
1
2018
22
0.160
 Why?
Methicillin-Resistant Staphylococcus aureus
2
2020
191
0.160
 Why?
Longitudinal Studies
4
2023
2387
0.150
 Why?
Angina, Stable
1
2018
17
0.150
 Why?
Drug Monitoring
2
2012
184
0.150
 Why?
Heart Failure
2
2021
1945
0.150
 Why?
Area Under Curve
1
2019
274
0.150
 Why?
Feasibility Studies
2
2020
740
0.150
 Why?
Anti-Citrullinated Protein Antibodies
1
2019
90
0.150
 Why?
Calcium Channel Blockers
1
2018
114
0.150
 Why?
Osteoarthritis
1
2020
171
0.150
 Why?
Communication
1
2023
744
0.150
 Why?
Rheumatologists
1
2017
12
0.150
 Why?
Professional Practice Location
1
2017
26
0.150
 Why?
Brain Ischemia
1
2021
299
0.150
 Why?
Sacroiliitis
1
2017
3
0.150
 Why?
Random Allocation
1
2018
335
0.150
 Why?
Neoplasm Metastasis
1
2019
523
0.140
 Why?
Population Surveillance
2
2012
392
0.140
 Why?
Obesity, Abdominal
1
2017
37
0.140
 Why?
Recovery of Function
1
2021
574
0.140
 Why?
Reverse Transcriptase Inhibitors
1
2018
82
0.140
 Why?
Prognosis
3
2020
3329
0.140
 Why?
Precision Medicine
1
2020
337
0.140
 Why?
Data Accuracy
1
2017
48
0.140
 Why?
Arthroplasty, Replacement, Knee
1
2021
246
0.140
 Why?
Protease Inhibitors
1
2018
97
0.140
 Why?
Hypertension
2
2018
1056
0.140
 Why?
Bias
3
2013
179
0.140
 Why?
Cross-Sectional Studies
6
2024
4410
0.140
 Why?
Leptin
3
2022
210
0.140
 Why?
Neoplasm Staging
1
2020
1167
0.140
 Why?
Disability Evaluation
1
2018
271
0.140
 Why?
HIV Integrase Inhibitors
1
2018
62
0.140
 Why?
Adverse Drug Reaction Reporting Systems
2
2007
68
0.140
 Why?
Forecasting
1
2018
330
0.140
 Why?
Travel
1
2017
121
0.140
 Why?
Risk Management
2
2007
89
0.140
 Why?
Pain
1
2022
705
0.140
 Why?
Anti-Inflammatory Agents
2
2018
447
0.130
 Why?
Dose-Response Relationship, Radiation
1
2016
127
0.130
 Why?
Adrenergic beta-Antagonists
1
2018
287
0.130
 Why?
Antimicrobial Stewardship
1
2018
94
0.130
 Why?
Cyclosporine
1
2016
161
0.130
 Why?
Obesity
2
2018
2508
0.130
 Why?
Observational Studies as Topic
1
2016
90
0.130
 Why?
Hospital Mortality
1
2020
776
0.130
 Why?
Fees, Pharmaceutical
1
2015
13
0.130
 Why?
Anti-Retroviral Agents
1
2018
207
0.130
 Why?
Drug Administration Routes
1
2015
40
0.130
 Why?
Anti-Infective Agents
1
2018
225
0.130
 Why?
Pseudomonas Infections
1
2017
184
0.130
 Why?
Suicide
1
2021
508
0.130
 Why?
Cause of Death
4
2023
361
0.130
 Why?
Logistic Models
2
2018
1841
0.120
 Why?
Cross Infection
1
2017
197
0.120
 Why?
Health Care Costs
1
2018
381
0.120
 Why?
Recombination, Genetic
3
2005
176
0.120
 Why?
Quality Improvement
1
2022
950
0.120
 Why?
Inflammation Mediators
1
2017
477
0.120
 Why?
Drug Administration Schedule
1
2016
718
0.120
 Why?
Glucocorticoids
1
2018
532
0.110
 Why?
Guideline Adherence
1
2018
490
0.110
 Why?
Health Expenditures
1
2015
171
0.110
 Why?
Telemedicine
1
2022
662
0.110
 Why?
Infusions, Intravenous
1
2014
371
0.110
 Why?
HIV Infections
2
2018
2469
0.110
 Why?
Prednisone
3
2021
229
0.110
 Why?
Causality
1
2013
103
0.110
 Why?
Adiposity
1
2017
458
0.110
 Why?
Socioeconomic Factors
2
2018
1079
0.110
 Why?
Mortality
1
2015
287
0.110
 Why?
Pneumonia
1
2018
568
0.100
 Why?
Integrases
3
2005
116
0.100
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
35
0.100
 Why?
Feedback
2
2023
144
0.100
 Why?
Education, Medical, Continuing
1
2013
117
0.100
 Why?
Root Cause Analysis
1
2012
8
0.100
 Why?
Lung Neoplasms
2
2022
2177
0.100
 Why?
HIV-1
1
2018
768
0.100
 Why?
Prescription Drug Misuse
1
2012
38
0.100
 Why?
Florida
1
2012
73
0.100
 Why?
Health Personnel
1
2017
574
0.100
 Why?
Adolescent
5
2015
17853
0.100
 Why?
Lung Diseases
1
2018
701
0.100
 Why?
Occupational Injuries
1
2012
46
0.100
 Why?
Outpatients
1
2014
326
0.100
 Why?
Narration
1
2012
44
0.100
 Why?
Antineoplastic Agents
1
2022
1879
0.090
 Why?
Internal Medicine
1
2013
211
0.090
 Why?
Reproducibility of Results
2
2016
2765
0.090
 Why?
Osteoporotic Fractures
1
2012
56
0.090
 Why?
Risk
1
2013
812
0.090
 Why?
Anti-Bacterial Agents
1
2020
1481
0.090
 Why?
Substance-Related Disorders
2
2023
947
0.090
 Why?
Young Adult
3
2015
10471
0.090
 Why?
Dose-Response Relationship, Drug
1
2014
1842
0.090
 Why?
Blood Pressure
2
2018
1538
0.080
 Why?
Sex Factors
3
2021
1715
0.080
 Why?
Machine Learning
2
2022
316
0.080
 Why?
Referral and Consultation
1
2013
635
0.080
 Why?
Pattern Recognition, Automated
1
2008
67
0.080
 Why?
Biomarkers
3
2024
3408
0.080
 Why?
Diagnosis, Computer-Assisted
1
2008
64
0.080
 Why?
Catheter-Related Infections
1
2008
62
0.070
 Why?
Hospital Records
1
2007
11
0.070
 Why?
Cost Sharing
1
2007
14
0.070
 Why?
Antihypertensive Agents
1
2011
429
0.070
 Why?
Financing, Personal
1
2007
25
0.070
 Why?
Artificial Intelligence
1
2008
144
0.070
 Why?
Nonlinear Dynamics
1
2007
83
0.070
 Why?
Viral Proteins
2
1999
281
0.070
 Why?
Insulin-Like Growth Factor I
2
1999
286
0.070
 Why?
Primary Health Care
2
2013
1514
0.070
 Why?
Mutagenesis, Site-Directed
2
2005
345
0.070
 Why?
Drug Interactions
1
2007
338
0.060
 Why?
Respiratory Tract Diseases
2
2017
138
0.060
 Why?
Mass Screening
1
2012
1005
0.060
 Why?
Models, Theoretical
1
2008
515
0.060
 Why?
Chronic Disease
2
2022
1578
0.060
 Why?
Mental Disorders
1
2012
893
0.060
 Why?
Health Services Research
1
2007
371
0.060
 Why?
Blotting, Southern
1
2004
68
0.060
 Why?
Data Collection
1
2007
620
0.060
 Why?
Myocardial Infarction
1
2011
927
0.060
 Why?
Interleukin-17
1
2024
104
0.060
 Why?
Health Status
2
2018
722
0.050
 Why?
Vital Capacity
1
2023
255
0.050
 Why?
Length of Stay
1
2007
962
0.050
 Why?
Odds Ratio
2
2018
953
0.050
 Why?
Acetazolamide
1
2022
30
0.050
 Why?
Telomere Shortening
1
2022
17
0.050
 Why?
Medicare
1
2007
665
0.050
 Why?
Antimanic Agents
1
2021
14
0.050
 Why?
Lithium
1
2021
36
0.050
 Why?
Valproic Acid
1
2021
43
0.050
 Why?
Zebrafish
1
2005
412
0.050
 Why?
Patient Discharge
2
2023
773
0.050
 Why?
Chlorambucil
1
2021
8
0.050
 Why?
Medication Therapy Management
1
2022
67
0.050
 Why?
Vidarabine
1
2021
26
0.050
 Why?
Bendamustine Hydrochloride
1
2021
11
0.050
 Why?
Bortezomib
1
2021
41
0.050
 Why?
Magnetic Resonance Imaging
2
2022
3053
0.050
 Why?
Vincristine
1
2021
98
0.040
 Why?
Pulmonologists
1
2020
16
0.040
 Why?
Data Display
1
2020
19
0.040
 Why?
Cerebrovascular Circulation
1
2022
221
0.040
 Why?
Telomere
1
2022
202
0.040
 Why?
Computed Tomography Angiography
1
2021
97
0.040
 Why?
Quality Control
1
2020
144
0.040
 Why?
Pharmacists
1
2022
234
0.040
 Why?
Doxorubicin
1
2021
285
0.040
 Why?
Piperidines
1
2021
160
0.040
 Why?
User-Computer Interface
1
2020
140
0.040
 Why?
Range of Motion, Articular
1
2021
350
0.040
 Why?
Bone Marrow Transplantation
1
2020
239
0.040
 Why?
Embryonic and Fetal Development
1
1999
94
0.040
 Why?
Magnetic Resonance Angiography
1
2021
220
0.040
 Why?
Adenine
1
2021
219
0.040
 Why?
Dexamethasone
1
2021
317
0.040
 Why?
Time-to-Treatment
1
2019
147
0.040
 Why?
Patient Satisfaction
1
2022
578
0.040
 Why?
Mental Health
1
2023
562
0.040
 Why?
Reoperation
1
2020
514
0.040
 Why?
Infant Mortality
1
1998
91
0.040
 Why?
Cost-Benefit Analysis
1
2020
544
0.040
 Why?
Gene Dosage
1
1998
129
0.040
 Why?
Recurrence
1
2020
935
0.040
 Why?
Methicillin Resistance
1
2017
18
0.040
 Why?
Gene Expression Regulation, Developmental
2
1999
801
0.040
 Why?
Critical Illness
1
2022
646
0.040
 Why?
Cardiovascular Agents
1
2018
126
0.040
 Why?
HIV Integrase
1
2018
67
0.030
 Why?
Rheumatic Nodule
1
2016
3
0.030
 Why?
Absorptiometry, Photon
1
2017
224
0.030
 Why?
Nutrition Surveys
1
2017
224
0.030
 Why?
Isoxazoles
1
2016
51
0.030
 Why?
Thinness
1
2016
87
0.030
 Why?
Viral Load
1
2018
405
0.030
 Why?
Body Weight
2
2016
869
0.030
 Why?
Community-Acquired Infections
1
2017
141
0.030
 Why?
Rheumatoid Factor
1
2016
157
0.030
 Why?
Lymphoma
1
2016
177
0.030
 Why?
Surveys and Questionnaires
2
2020
4624
0.030
 Why?
Survival Analysis
1
2018
1211
0.030
 Why?
Analysis of Variance
1
2018
1226
0.030
 Why?
Peptides, Cyclic
1
2016
253
0.030
 Why?
Leukemia
1
2016
209
0.030
 Why?
Tomography, X-Ray Computed
1
2023
2286
0.030
 Why?
Age Factors
1
2021
2894
0.030
 Why?
Quality of Health Care
1
2018
573
0.030
 Why?
Life Style
1
2016
430
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1355
0.030
 Why?
Workers' Compensation
1
2012
27
0.030
 Why?
Inflammation
1
2022
2480
0.030
 Why?
Coroners and Medical Examiners
1
2011
7
0.020
 Why?
Death Certificates
1
2011
30
0.020
 Why?
Sampling Studies
1
2011
93
0.020
 Why?
Brain
1
2022
2371
0.020
 Why?
Pancreatic Neoplasms
1
2016
731
0.020
 Why?
Prostatic Neoplasms
1
2016
921
0.020
 Why?
Smoking
1
2016
1383
0.020
 Why?
Quality of Life
1
2019
2353
0.020
 Why?
Child
1
2007
18420
0.020
 Why?
Medical Assistance
1
2007
13
0.020
 Why?
Deductibles and Coinsurance
1
2007
9
0.020
 Why?
Models, Econometric
1
2007
34
0.020
 Why?
Psychoses, Substance-Induced
1
2007
12
0.020
 Why?
Inpatients
1
2011
380
0.020
 Why?
Eligibility Determination
1
2007
60
0.020
 Why?
Evidence-Based Medicine
1
2011
668
0.020
 Why?
Costs and Cost Analysis
1
2007
196
0.020
 Why?
Delirium
1
2007
66
0.020
 Why?
Insurance Coverage
1
2007
200
0.020
 Why?
beta-Galactosidase
1
2005
62
0.020
 Why?
HSP70 Heat-Shock Proteins
1
2005
61
0.020
 Why?
Blood Coagulation Disorders
1
2007
197
0.020
 Why?
Mosaicism
1
2005
61
0.020
 Why?
Genes, Reporter
1
2005
257
0.010
 Why?
Animals, Genetically Modified
1
2005
216
0.010
 Why?
Sensitivity and Specificity
1
2008
1693
0.010
 Why?
Case-Control Studies
1
2011
3003
0.010
 Why?
Mice, Transgenic
2
1999
1950
0.010
 Why?
Hemorrhage
1
2007
620
0.010
 Why?
Recombinant Fusion Proteins
1
2005
616
0.010
 Why?
Liver
2
1999
1637
0.010
 Why?
Growth Disorders
1
1998
77
0.010
 Why?
Animals
3
2005
31708
0.010
 Why?
Mice
2
1999
14871
0.010
 Why?
RNA, Messenger
1
1998
2553
0.010
 Why?
Infant, Newborn
1
1998
5047
0.000
 Why?
Sauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (391) concept(s)
_
Co-Authors Expand Description
See all (8) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)